Company Overview and News
The U.S. stock market is showing strong complacency amid trade fears, with the S&P 500 and Dow Jones hitting new highs. While most of the sectors have been rallying, a few are lagging behind and financials is one of them. However, this seems to be the right time to get into this sector stocks and ETFs. Below, we have highlighted some strong reasons for the outperformance of the broader sector: Rising Rates Rates have been on the rise this year with 10-year Treasury yields hovering above 3% and 2-year yields near a decade high of 2.
7018 CME KRE KBE EOG
The cryptocurrency market’s credibility took a hit late Wednesday New York time when Japanese exchange Zaif said it had been hacked, resulting in the loss of nearly 6,000 bitcoin.
BEIJING, Sept 20 (Reuters) - The Shanghai Futures Exchange (ShFE) will launch copper options trading on Friday, aiming to take a slice of a $270 billion global market in one of its biggest challenges yet to London and New York rivals.
0358 7018 CME
SHANGHAI, Sept 20 (Reuters) - The Shanghai Futures Exchange (ShFE) aims to release a draft of an alumina futures contract in late 2018 or early 2019, after requests from the market to create a price benchmark for the feedstock used to make aluminium, an official said on Thursday.
Hard pressed to quash allegations that its popular "fear gauge" is being manipulated, Cboe Global Markets is turning to artificial intelligence to help put those concerns to rest.
NDAQ 7018 CME ICE
BEIJING (Reuters) - The Shanghai Futures Exchange (ShFE) will launch copper options trading on Friday, aiming to take a slice of a $270 billion global market in one of its biggest challenges yet to London and New York rivals.
0358 7018 CME
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Walmart (WMT), IBM (IBM) and Texas Instruments (TXN). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
WFCNP SOJA LMT TXN GAS WMT CME WFC SO 7018 URI OXY
Bitcoin BTCUSD, +2.03% the worlds largest digital currency, lost as much as 4% late Monday, hitting a low of $6,213.46, inching closer to critical support near $6,000. In early Tuesday trading a single bitcoin was last going for $6,267.68, up 0.8% since Monday at 5 p.m. Eastern Time on the Kraken cryptocurrency exchange.
The S&P 500 closed out the third week of September 2018 on an upnote, but not by so much that it resumed setting the kind of new record highs that it was just a few weeks ago.
EIA has developed an interactive dashboard that provides daily and weekly contextual information to the Weekly Natural Gas Storage Report (WNGSR). The new dashboard shows Lower 48 and regional storage activity and key market fundamentals that affect underground natural gas storage activity.
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...